nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—L-DOPA—Melphalan—breast cancer	0.189	1	CrCrCtD
Epinephrine—TNF—breast cancer	0.163	0.673	CbGaD
Epinephrine—CYP3A4—breast cancer	0.0792	0.327	CbGaD
Epinephrine—CYP1A2—Anastrozole—breast cancer	0.0249	0.0896	CbGbCtD
Epinephrine—CYP1A2—Toremifene—breast cancer	0.0228	0.0819	CbGbCtD
Epinephrine—CYP2C9—Anastrozole—breast cancer	0.0225	0.0807	CbGbCtD
Epinephrine—SLC22A2—Vinblastine—breast cancer	0.0187	0.0671	CbGbCtD
Epinephrine—CYP3A4—Exemestane—breast cancer	0.0172	0.0619	CbGbCtD
Epinephrine—CYP2C9—Idarubicin—breast cancer	0.017	0.0612	CbGbCtD
Epinephrine—CYP3A4—Letrozole—breast cancer	0.0147	0.0527	CbGbCtD
Epinephrine—CYP3A4—Anastrozole—breast cancer	0.0131	0.0469	CbGbCtD
Epinephrine—CYP3A4—Toremifene—breast cancer	0.0119	0.0429	CbGbCtD
Epinephrine—CYP3A4—Fulvestrant—breast cancer	0.0111	0.0399	CbGbCtD
Epinephrine—CYP3A4—Thiotepa—breast cancer	0.0099	0.0356	CbGbCtD
Epinephrine—CYP2C9—Capecitabine—breast cancer	0.00933	0.0335	CbGbCtD
Epinephrine—CYP3A4—Ixabepilone—breast cancer	0.00905	0.0325	CbGbCtD
Epinephrine—CYP3A4—Lapatinib—breast cancer	0.00871	0.0313	CbGbCtD
Epinephrine—CYP1A2—Tamoxifen—breast cancer	0.00833	0.0299	CbGbCtD
Epinephrine—CYP2C9—Tamoxifen—breast cancer	0.0075	0.027	CbGbCtD
Epinephrine—CYP3A4—Raloxifene—breast cancer	0.0066	0.0237	CbGbCtD
Epinephrine—CYP1A2—Fluorouracil—breast cancer	0.00614	0.0221	CbGbCtD
Epinephrine—CYP2C9—Paclitaxel—breast cancer	0.00584	0.021	CbGbCtD
Epinephrine—CYP2C9—Fluorouracil—breast cancer	0.00553	0.0199	CbGbCtD
Epinephrine—CYP3A4—Vinorelbine—breast cancer	0.00483	0.0174	CbGbCtD
Epinephrine—CYP3A4—Tamoxifen—breast cancer	0.00436	0.0157	CbGbCtD
Epinephrine—CYP3A4—Mitoxantrone—breast cancer	0.00426	0.0153	CbGbCtD
Epinephrine—CYP3A4—Paclitaxel—breast cancer	0.0034	0.0122	CbGbCtD
Epinephrine—CYP3A4—Irinotecan—breast cancer	0.00335	0.012	CbGbCtD
Epinephrine—CYP3A4—Vinblastine—breast cancer	0.00298	0.0107	CbGbCtD
Epinephrine—CYP3A4—Docetaxel—breast cancer	0.00246	0.00882	CbGbCtD
Epinephrine—ADRBK1—mammary gland—breast cancer	0.00203	0.0743	CbGeAlD
Epinephrine—CYP3A4—Doxorubicin—breast cancer	0.00183	0.00658	CbGbCtD
Epinephrine—ADRBK1—embryo—breast cancer	0.00138	0.0507	CbGeAlD
Epinephrine—ADRB3—adipose tissue—breast cancer	0.000934	0.0342	CbGeAlD
Epinephrine—PAH—endocrine gland—breast cancer	0.00093	0.0341	CbGeAlD
Epinephrine—ADRBK1—adipose tissue—breast cancer	0.000912	0.0335	CbGeAlD
Epinephrine—ADRB3—female reproductive system—breast cancer	0.000858	0.0315	CbGeAlD
Epinephrine—TNF—lymph node—breast cancer	0.000854	0.0313	CbGeAlD
Epinephrine—ADRBK1—female reproductive system—breast cancer	0.000839	0.0308	CbGeAlD
Epinephrine—ADRBK1—adrenal gland—breast cancer	0.000818	0.03	CbGeAlD
Epinephrine—ADRBK1—bone marrow—breast cancer	0.000792	0.029	CbGeAlD
Epinephrine—ADRB3—female gonad—breast cancer	0.000781	0.0286	CbGeAlD
Epinephrine—ADRBK1—female gonad—breast cancer	0.000763	0.028	CbGeAlD
Epinephrine—Dipivefrin—ACHE—breast cancer	0.000754	0.287	CrCbGaD
Epinephrine—ADRBK1—endocrine gland—breast cancer	0.00071	0.026	CbGeAlD
Epinephrine—ADRA1D—epithelium—breast cancer	0.00065	0.0238	CbGeAlD
Epinephrine—SLC22A5—mammary gland—breast cancer	0.000612	0.0224	CbGeAlD
Epinephrine—ADRA2C—nipple—breast cancer	0.000529	0.0194	CbGeAlD
Epinephrine—CYP2C9—mammary gland—breast cancer	0.000526	0.0193	CbGeAlD
Epinephrine—SLC22A5—nipple—breast cancer	0.000506	0.0186	CbGeAlD
Epinephrine—ADRBK1—lymph node—breast cancer	0.000491	0.018	CbGeAlD
Epinephrine—ADRA1D—female reproductive system—breast cancer	0.000483	0.0177	CbGeAlD
Epinephrine—CYP1A2—nipple—breast cancer	0.000459	0.0168	CbGeAlD
Epinephrine—Dipivefrin—BCHE—breast cancer	0.000443	0.169	CrCbGaD
Epinephrine—Methyldopa—COMT—breast cancer	0.000435	0.166	CrCbGaD
Epinephrine—ADRA2A—nipple—breast cancer	0.000422	0.0155	CbGeAlD
Epinephrine—ADRA1D—endocrine gland—breast cancer	0.000409	0.015	CbGeAlD
Epinephrine—SLC22A1—adipose tissue—breast cancer	0.000396	0.0145	CbGeAlD
Epinephrine—Terbutaline—BCHE—breast cancer	0.000384	0.146	CrCbGaD
Epinephrine—ADRB1—adipose tissue—breast cancer	0.000382	0.014	CbGeAlD
Epinephrine—ADRA1A—epithelium—breast cancer	0.000373	0.0137	CbGeAlD
Epinephrine—ADRB1—female reproductive system—breast cancer	0.000351	0.0129	CbGeAlD
Epinephrine—SLC22A5—skin of body—breast cancer	0.000324	0.0119	CbGeAlD
Epinephrine—ADRA2C—endometrium—breast cancer	0.000319	0.0117	CbGeAlD
Epinephrine—SLC22A1—endocrine gland—breast cancer	0.000308	0.0113	CbGeAlD
Epinephrine—SLC22A5—endometrium—breast cancer	0.000306	0.0112	CbGeAlD
Epinephrine—ADRA1A—adipose tissue—breast cancer	0.000302	0.0111	CbGeAlD
Epinephrine—ADRB1—endocrine gland—breast cancer	0.000297	0.0109	CbGeAlD
Epinephrine—ADRA2C—uterus—breast cancer	0.000294	0.0108	CbGeAlD
Epinephrine—ADRA2C—pituitary gland—breast cancer	0.000289	0.0106	CbGeAlD
Epinephrine—ADRA2C—adipose tissue—breast cancer	0.000288	0.0105	CbGeAlD
Epinephrine—SLC22A5—pituitary gland—breast cancer	0.000277	0.0101	CbGeAlD
Epinephrine—SLC22A5—adipose tissue—breast cancer	0.000275	0.0101	CbGeAlD
Epinephrine—ADRA1A—adrenal gland—breast cancer	0.000271	0.00993	CbGeAlD
Epinephrine—ADRA2C—adrenal gland—breast cancer	0.000258	0.00946	CbGeAlD
Epinephrine—ADRA2A—endometrium—breast cancer	0.000255	0.00934	CbGeAlD
Epinephrine—SLC22A5—female reproductive system—breast cancer	0.000253	0.00929	CbGeAlD
Epinephrine—SLC22A5—adrenal gland—breast cancer	0.000247	0.00906	CbGeAlD
Epinephrine—ADRA2C—female gonad—breast cancer	0.000241	0.00882	CbGeAlD
Epinephrine—ADRA1A—endocrine gland—breast cancer	0.000235	0.00861	CbGeAlD
Epinephrine—ADRA2A—uterus—breast cancer	0.000235	0.00861	CbGeAlD
Epinephrine—ADRA2A—pituitary gland—breast cancer	0.00023	0.00845	CbGeAlD
Epinephrine—SLC22A5—female gonad—breast cancer	0.00023	0.00845	CbGeAlD
Epinephrine—ADRA2A—adipose tissue—breast cancer	0.000229	0.00842	CbGeAlD
Epinephrine—CYP2C9—female reproductive system—breast cancer	0.000218	0.00799	CbGeAlD
Epinephrine—Dopamine—COMT—breast cancer	0.000212	0.0808	CrCbGaD
Epinephrine—ADRA2A—female reproductive system—breast cancer	0.000211	0.00774	CbGeAlD
Epinephrine—ADRA2A—adrenal gland—breast cancer	0.000206	0.00755	CbGeAlD
Epinephrine—CYP1A2—endocrine gland—breast cancer	0.000194	0.00712	CbGeAlD
Epinephrine—ADRA2A—female gonad—breast cancer	0.000192	0.00704	CbGeAlD
Epinephrine—CYP2C9—endocrine gland—breast cancer	0.000184	0.00676	CbGeAlD
Epinephrine—ADRA2A—endocrine gland—breast cancer	0.000179	0.00655	CbGeAlD
Epinephrine—CYP3A4—female reproductive system—breast cancer	0.000166	0.00609	CbGeAlD
Epinephrine—ADRA2C—lymph node—breast cancer	0.000155	0.00567	CbGeAlD
Epinephrine—SLC22A5—lymph node—breast cancer	0.000148	0.00543	CbGeAlD
Epinephrine—CYP3A4—endocrine gland—breast cancer	0.000141	0.00515	CbGeAlD
Epinephrine—Salbutamol—CYP3A4—breast cancer	0.000134	0.0512	CrCbGaD
Epinephrine—ADRA2A—lymph node—breast cancer	0.000123	0.00453	CbGeAlD
Epinephrine—Nausea—Letrozole—breast cancer	0.00012	0.000897	CcSEcCtD
Epinephrine—Erythema—Mitoxantrone—breast cancer	0.000119	0.000893	CcSEcCtD
Epinephrine—Hypertension—Thiotepa—breast cancer	0.000119	0.000893	CcSEcCtD
Epinephrine—Arrhythmia—Gemcitabine—breast cancer	0.000119	0.000893	CcSEcCtD
Epinephrine—Insomnia—Goserelin—breast cancer	0.000119	0.000893	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000119	0.000892	CcSEcCtD
Epinephrine—Paraesthesia—Goserelin—breast cancer	0.000118	0.000886	CcSEcCtD
Epinephrine—Arrhythmia—Fluorouracil—breast cancer	0.000117	0.000878	CcSEcCtD
Epinephrine—Somnolence—Goserelin—breast cancer	0.000117	0.000877	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000117	0.000874	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Melphalan—breast cancer	0.000117	0.000873	CcSEcCtD
Epinephrine—Erythema—Gemcitabine—breast cancer	0.000116	0.00087	CcSEcCtD
Epinephrine—Nervous system disorder—Vinorelbine—breast cancer	0.000116	0.000867	CcSEcCtD
Epinephrine—Tachycardia—Vinorelbine—breast cancer	0.000115	0.000863	CcSEcCtD
Epinephrine—Skin disorder—Vinorelbine—breast cancer	0.000115	0.000858	CcSEcCtD
Epinephrine—Erythema—Fluorouracil—breast cancer	0.000114	0.000855	CcSEcCtD
Epinephrine—Nausea—Idarubicin—breast cancer	0.000114	0.000851	CcSEcCtD
Epinephrine—Nausea—Raloxifene—breast cancer	0.000114	0.000851	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—breast cancer	0.000113	0.000848	CcSEcCtD
Epinephrine—Isoprenaline—CYP1A1—breast cancer	0.000113	0.0431	CrCbGaD
Epinephrine—Skin exfoliation—Doxorubicin—breast cancer	0.000112	0.000842	CcSEcCtD
Epinephrine—Haemoglobin—Paclitaxel—breast cancer	0.000112	0.000841	CcSEcCtD
Epinephrine—Haemorrhage—Paclitaxel—breast cancer	0.000112	0.000837	CcSEcCtD
Epinephrine—Sweating increased—Capecitabine—breast cancer	0.000112	0.000836	CcSEcCtD
Epinephrine—Hypoaesthesia—Paclitaxel—breast cancer	0.000111	0.000833	CcSEcCtD
Epinephrine—Nervous system disorder—Thiotepa—breast cancer	0.000111	0.000828	CcSEcCtD
Epinephrine—Tachycardia—Thiotepa—breast cancer	0.00011	0.000824	CcSEcCtD
Epinephrine—Skin disorder—Thiotepa—breast cancer	0.00011	0.00082	CcSEcCtD
Epinephrine—Paraesthesia—Vinorelbine—breast cancer	0.000106	0.000794	CcSEcCtD
Epinephrine—Pulmonary oedema—Doxorubicin—breast cancer	0.000105	0.000785	CcSEcCtD
Epinephrine—Acute coronary syndrome—Docetaxel—breast cancer	0.000104	0.000779	CcSEcCtD
Epinephrine—Renal failure—Docetaxel—breast cancer	0.000104	0.000777	CcSEcCtD
Epinephrine—Flushing—Paclitaxel—breast cancer	0.000104	0.000777	CcSEcCtD
Epinephrine—Myocardial infarction—Docetaxel—breast cancer	0.000104	0.000774	CcSEcCtD
Epinephrine—Hyperglycaemia—Capecitabine—breast cancer	0.000103	0.000774	CcSEcCtD
Epinephrine—Hypertension—Irinotecan—breast cancer	0.000103	0.000771	CcSEcCtD
Epinephrine—Hypertension—Mitoxantrone—breast cancer	0.000103	0.000771	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000102	0.000763	CcSEcCtD
Epinephrine—Chest pain—Mitoxantrone—breast cancer	0.000102	0.00076	CcSEcCtD
Epinephrine—Paraesthesia—Thiotepa—breast cancer	0.000101	0.000758	CcSEcCtD
Epinephrine—Acute coronary syndrome—Capecitabine—breast cancer	0.000101	0.000754	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—breast cancer	0.000101	0.000754	CcSEcCtD
Epinephrine—Renal failure—Capecitabine—breast cancer	0.000101	0.000752	CcSEcCtD
Epinephrine—Hypertension—Gemcitabine—breast cancer	0.0001	0.000751	CcSEcCtD
Epinephrine—Somnolence—Thiotepa—breast cancer	0.0001	0.00075	CcSEcCtD
Epinephrine—Myocardial infarction—Capecitabine—breast cancer	0.0001	0.00075	CcSEcCtD
Epinephrine—Arrhythmia—Paclitaxel—breast cancer	9.99e-05	0.000748	CcSEcCtD
Epinephrine—Chest pain—Gemcitabine—breast cancer	9.9e-05	0.000741	CcSEcCtD
Epinephrine—Vomiting—Chlorambucil—breast cancer	9.86e-05	0.000738	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	9.83e-05	0.000736	CcSEcCtD
Epinephrine—Mental disorder—Paclitaxel—breast cancer	9.8e-05	0.000733	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Thiotepa—breast cancer	9.74e-05	0.000729	CcSEcCtD
Epinephrine—Erythema—Paclitaxel—breast cancer	9.74e-05	0.000728	CcSEcCtD
Epinephrine—Chest pain—Fluorouracil—breast cancer	9.74e-05	0.000728	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—breast cancer	9.71e-05	0.000727	CcSEcCtD
Epinephrine—Nervous system disorder—Irinotecan—breast cancer	9.56e-05	0.000715	CcSEcCtD
Epinephrine—Tension—Paclitaxel—breast cancer	9.56e-05	0.000715	CcSEcCtD
Epinephrine—Haemoglobin—Docetaxel—breast cancer	9.53e-05	0.000713	CcSEcCtD
Epinephrine—Tachycardia—Mitoxantrone—breast cancer	9.51e-05	0.000711	CcSEcCtD
Epinephrine—Haemorrhage—Docetaxel—breast cancer	9.48e-05	0.000709	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—breast cancer	9.47e-05	0.000709	CcSEcCtD
Epinephrine—Skin disorder—Mitoxantrone—breast cancer	9.47e-05	0.000708	CcSEcCtD
Epinephrine—Nervousness—Paclitaxel—breast cancer	9.46e-05	0.000707	CcSEcCtD
Epinephrine—Hypoaesthesia—Docetaxel—breast cancer	9.43e-05	0.000706	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—breast cancer	9.43e-05	0.000706	CcSEcCtD
Epinephrine—Hyperhidrosis—Irinotecan—breast cancer	9.42e-05	0.000705	CcSEcCtD
Epinephrine—Hyperhidrosis—Mitoxantrone—breast cancer	9.42e-05	0.000705	CcSEcCtD
Epinephrine—Dizziness—Vinblastine—breast cancer	9.4e-05	0.000703	CcSEcCtD
Epinephrine—Nervous system disorder—Gemcitabine—breast cancer	9.31e-05	0.000696	CcSEcCtD
Epinephrine—Haemoglobin—Capecitabine—breast cancer	9.23e-05	0.00069	CcSEcCtD
Epinephrine—Skin disorder—Gemcitabine—breast cancer	9.22e-05	0.00069	CcSEcCtD
Epinephrine—Nausea—Chlorambucil—breast cancer	9.22e-05	0.000689	CcSEcCtD
Epinephrine—Haemorrhage—Capecitabine—breast cancer	9.18e-05	0.000687	CcSEcCtD
Epinephrine—Hyperhidrosis—Gemcitabine—breast cancer	9.18e-05	0.000686	CcSEcCtD
Epinephrine—Nervous system disorder—Fluorouracil—breast cancer	9.15e-05	0.000685	CcSEcCtD
Epinephrine—Hypoaesthesia—Capecitabine—breast cancer	9.13e-05	0.000683	CcSEcCtD
Epinephrine—Dizziness—Tamoxifen—breast cancer	9.13e-05	0.000683	CcSEcCtD
Epinephrine—Tachycardia—Fluorouracil—breast cancer	9.11e-05	0.000681	CcSEcCtD
Epinephrine—Vomiting—Vinblastine—breast cancer	9.04e-05	0.000676	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—breast cancer	8.99e-05	0.000672	CcSEcCtD
Epinephrine—Agitation—Paclitaxel—breast cancer	8.95e-05	0.000669	CcSEcCtD
Epinephrine—Insomnia—Irinotecan—breast cancer	8.81e-05	0.000659	CcSEcCtD
Epinephrine—Flushing—Docetaxel—breast cancer	8.8e-05	0.000658	CcSEcCtD
Epinephrine—Vomiting—Tamoxifen—breast cancer	8.78e-05	0.000657	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—breast cancer	8.76e-05	0.000656	CcSEcCtD
Epinephrine—Paraesthesia—Mitoxantrone—breast cancer	8.75e-05	0.000655	CcSEcCtD
Epinephrine—Paraesthesia—Irinotecan—breast cancer	8.75e-05	0.000655	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—breast cancer	8.73e-05	0.000653	CcSEcCtD
Epinephrine—Dizziness—Goserelin—breast cancer	8.72e-05	0.000653	CcSEcCtD
Epinephrine—Somnolence—Mitoxantrone—breast cancer	8.66e-05	0.000648	CcSEcCtD
Epinephrine—Somnolence—Irinotecan—breast cancer	8.66e-05	0.000648	CcSEcCtD
Epinephrine—Palpitations—Paclitaxel—breast cancer	8.61e-05	0.000644	CcSEcCtD
Epinephrine—Vomiting—Melphalan—breast cancer	8.6e-05	0.000643	CcSEcCtD
Epinephrine—Insomnia—Gemcitabine—breast cancer	8.59e-05	0.000642	CcSEcCtD
Epinephrine—Paraesthesia—Gemcitabine—breast cancer	8.52e-05	0.000638	CcSEcCtD
Epinephrine—Flushing—Capecitabine—breast cancer	8.52e-05	0.000637	CcSEcCtD
Epinephrine—Arrhythmia—Docetaxel—breast cancer	8.47e-05	0.000634	CcSEcCtD
Epinephrine—Nausea—Vinblastine—breast cancer	8.45e-05	0.000632	CcSEcCtD
Epinephrine—Insomnia—Fluorouracil—breast cancer	8.44e-05	0.000631	CcSEcCtD
Epinephrine—Somnolence—Gemcitabine—breast cancer	8.44e-05	0.000631	CcSEcCtD
Epinephrine—Hypokalaemia—Epirubicin—breast cancer	8.41e-05	0.000629	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Irinotecan—breast cancer	8.41e-05	0.000629	CcSEcCtD
Epinephrine—Hypertension—Paclitaxel—breast cancer	8.41e-05	0.000629	CcSEcCtD
Epinephrine—Vomiting—Goserelin—breast cancer	8.39e-05	0.000627	CcSEcCtD
Epinephrine—Paraesthesia—Fluorouracil—breast cancer	8.38e-05	0.000627	CcSEcCtD
Epinephrine—Mental disorder—Docetaxel—breast cancer	8.31e-05	0.000621	CcSEcCtD
Epinephrine—Somnolence—Fluorouracil—breast cancer	8.3e-05	0.000621	CcSEcCtD
Epinephrine—Chest pain—Paclitaxel—breast cancer	8.29e-05	0.00062	CcSEcCtD
Epinephrine—Erythema—Docetaxel—breast cancer	8.25e-05	0.000617	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	8.23e-05	0.000616	CcSEcCtD
Epinephrine—Nausea—Tamoxifen—breast cancer	8.2e-05	0.000614	CcSEcCtD
Epinephrine—Arrhythmia—Capecitabine—breast cancer	8.2e-05	0.000613	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Gemcitabine—breast cancer	8.2e-05	0.000613	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Fluorouracil—breast cancer	8.06e-05	0.000603	CcSEcCtD
Epinephrine—Mental disorder—Capecitabine—breast cancer	8.04e-05	0.000602	CcSEcCtD
Epinephrine—Nausea—Melphalan—breast cancer	8.03e-05	0.000601	CcSEcCtD
Epinephrine—Erythema—Capecitabine—breast cancer	7.99e-05	0.000598	CcSEcCtD
Epinephrine—Nausea—Goserelin—breast cancer	7.84e-05	0.000586	CcSEcCtD
Epinephrine—Dizziness—Vinorelbine—breast cancer	7.81e-05	0.000584	CcSEcCtD
Epinephrine—L-DOPA—CYP2D6—breast cancer	7.8e-05	0.0297	CrCbGaD
Epinephrine—Nervous system disorder—Paclitaxel—breast cancer	7.79e-05	0.000583	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—breast cancer	7.78e-05	0.000582	CcSEcCtD
Epinephrine—Tachycardia—Paclitaxel—breast cancer	7.76e-05	0.00058	CcSEcCtD
Epinephrine—Skin disorder—Paclitaxel—breast cancer	7.72e-05	0.000577	CcSEcCtD
Epinephrine—Hyperhidrosis—Paclitaxel—breast cancer	7.68e-05	0.000575	CcSEcCtD
Epinephrine—Drowsiness—Methotrexate—breast cancer	7.61e-05	0.000569	CcSEcCtD
Epinephrine—Vomiting—Vinorelbine—breast cancer	7.51e-05	0.000562	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—breast cancer	7.48e-05	0.00056	CcSEcCtD
Epinephrine—Dizziness—Thiotepa—breast cancer	7.46e-05	0.000558	CcSEcCtD
Epinephrine—Sweating—Methotrexate—breast cancer	7.3e-05	0.000546	CcSEcCtD
Epinephrine—Palpitations—Docetaxel—breast cancer	7.29e-05	0.000546	CcSEcCtD
Epinephrine—Dopamine—CYP2D6—breast cancer	7.25e-05	0.0276	CrCbGaD
Epinephrine—Hyperglycaemia—Epirubicin—breast cancer	7.21e-05	0.000539	CcSEcCtD
Epinephrine—Insomnia—Paclitaxel—breast cancer	7.19e-05	0.000538	CcSEcCtD
Epinephrine—Vomiting—Thiotepa—breast cancer	7.17e-05	0.000537	CcSEcCtD
Epinephrine—Paraesthesia—Paclitaxel—breast cancer	7.14e-05	0.000534	CcSEcCtD
Epinephrine—Hypertension—Docetaxel—breast cancer	7.13e-05	0.000533	CcSEcCtD
Epinephrine—Drowsiness—Epirubicin—breast cancer	7.12e-05	0.000533	CcSEcCtD
Epinephrine—Somnolence—Paclitaxel—breast cancer	7.07e-05	0.000528	CcSEcCtD
Epinephrine—Palpitations—Capecitabine—breast cancer	7.06e-05	0.000528	CcSEcCtD
Epinephrine—Chest pain—Docetaxel—breast cancer	7.03e-05	0.000526	CcSEcCtD
Epinephrine—Nausea—Vinorelbine—breast cancer	7.02e-05	0.000525	CcSEcCtD
Epinephrine—Renal failure—Epirubicin—breast cancer	7e-05	0.000524	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.98e-05	0.000522	CcSEcCtD
Epinephrine—Hypertension—Capecitabine—breast cancer	6.9e-05	0.000516	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—breast cancer	6.87e-05	0.000514	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Paclitaxel—breast cancer	6.86e-05	0.000513	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—breast cancer	6.83e-05	0.000511	CcSEcCtD
Epinephrine—Sweating—Epirubicin—breast cancer	6.83e-05	0.000511	CcSEcCtD
Epinephrine—Chest pain—Capecitabine—breast cancer	6.8e-05	0.000509	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.76e-05	0.000505	CcSEcCtD
Epinephrine—Nausea—Thiotepa—breast cancer	6.7e-05	0.000501	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—breast cancer	6.67e-05	0.000499	CcSEcCtD
Epinephrine—Nervous system disorder—Docetaxel—breast cancer	6.61e-05	0.000494	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—breast cancer	6.59e-05	0.000493	CcSEcCtD
Epinephrine—Tachycardia—Docetaxel—breast cancer	6.57e-05	0.000492	CcSEcCtD
Epinephrine—Skin disorder—Docetaxel—breast cancer	6.54e-05	0.000489	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—breast cancer	6.48e-05	0.000485	CcSEcCtD
Epinephrine—Dizziness—Irinotecan—breast cancer	6.44e-05	0.000482	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—breast cancer	6.43e-05	0.000481	CcSEcCtD
Epinephrine—Nervous system disorder—Capecitabine—breast cancer	6.4e-05	0.000478	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—breast cancer	6.4e-05	0.000478	CcSEcCtD
Epinephrine—Tachycardia—Capecitabine—breast cancer	6.37e-05	0.000476	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—breast cancer	6.36e-05	0.000476	CcSEcCtD
Epinephrine—Skin disorder—Capecitabine—breast cancer	6.33e-05	0.000474	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—breast cancer	6.32e-05	0.000473	CcSEcCtD
Epinephrine—Hyperhidrosis—Capecitabine—breast cancer	6.3e-05	0.000472	CcSEcCtD
Epinephrine—Vomiting—Mitoxantrone—breast cancer	6.2e-05	0.000463	CcSEcCtD
Epinephrine—Vomiting—Irinotecan—breast cancer	6.2e-05	0.000463	CcSEcCtD
Epinephrine—Dizziness—Fluorouracil—breast cancer	6.17e-05	0.000462	CcSEcCtD
Epinephrine—Insomnia—Docetaxel—breast cancer	6.09e-05	0.000456	CcSEcCtD
Epinephrine—Paraesthesia—Docetaxel—breast cancer	6.05e-05	0.000452	CcSEcCtD
Epinephrine—Vomiting—Gemcitabine—breast cancer	6.04e-05	0.000451	CcSEcCtD
Epinephrine—Somnolence—Docetaxel—breast cancer	5.99e-05	0.000448	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—breast cancer	5.99e-05	0.000448	CcSEcCtD
Epinephrine—Erythema—Methotrexate—breast cancer	5.95e-05	0.000445	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—breast cancer	5.95e-05	0.000445	CcSEcCtD
Epinephrine—Flushing—Epirubicin—breast cancer	5.94e-05	0.000444	CcSEcCtD
Epinephrine—Vomiting—Fluorouracil—breast cancer	5.93e-05	0.000444	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—breast cancer	5.92e-05	0.000443	CcSEcCtD
Epinephrine—Insomnia—Capecitabine—breast cancer	5.9e-05	0.000441	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—breast cancer	5.89e-05	0.00044	CcSEcCtD
Epinephrine—Paraesthesia—Capecitabine—breast cancer	5.86e-05	0.000438	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Docetaxel—breast cancer	5.82e-05	0.000435	CcSEcCtD
Epinephrine—Nausea—Mitoxantrone—breast cancer	5.79e-05	0.000433	CcSEcCtD
Epinephrine—Nausea—Irinotecan—breast cancer	5.79e-05	0.000433	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—breast cancer	5.71e-05	0.000427	CcSEcCtD
Epinephrine—Nausea—Gemcitabine—breast cancer	5.64e-05	0.000422	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Capecitabine—breast cancer	5.63e-05	0.000421	CcSEcCtD
Epinephrine—Mental disorder—Epirubicin—breast cancer	5.6e-05	0.000419	CcSEcCtD
Epinephrine—Erythema—Epirubicin—breast cancer	5.57e-05	0.000416	CcSEcCtD
Epinephrine—Nausea—Fluorouracil—breast cancer	5.54e-05	0.000415	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—breast cancer	5.49e-05	0.000411	CcSEcCtD
Epinephrine—Tension—Epirubicin—breast cancer	5.46e-05	0.000409	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—breast cancer	5.41e-05	0.000404	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—breast cancer	5.29e-05	0.000395	CcSEcCtD
Epinephrine—Dizziness—Paclitaxel—breast cancer	5.26e-05	0.000393	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—breast cancer	5.18e-05	0.000388	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—breast cancer	5.15e-05	0.000385	CcSEcCtD
Epinephrine—Agitation—Epirubicin—breast cancer	5.12e-05	0.000383	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—breast cancer	5.06e-05	0.000379	CcSEcCtD
Epinephrine—Tension—Doxorubicin—breast cancer	5.05e-05	0.000378	CcSEcCtD
Epinephrine—Vomiting—Paclitaxel—breast cancer	5.05e-05	0.000378	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.03e-05	0.000376	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—breast cancer	5e-05	0.000374	CcSEcCtD
Epinephrine—Palpitations—Epirubicin—breast cancer	4.92e-05	0.000368	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—breast cancer	4.81e-05	0.00036	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—breast cancer	4.76e-05	0.000356	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—breast cancer	4.74e-05	0.000355	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—breast cancer	4.73e-05	0.000354	CcSEcCtD
Epinephrine—Nausea—Paclitaxel—breast cancer	4.72e-05	0.000353	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—breast cancer	4.72e-05	0.000353	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.71e-05	0.000352	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—breast cancer	4.69e-05	0.000351	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—breast cancer	4.55e-05	0.000341	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—breast cancer	4.46e-05	0.000333	CcSEcCtD
Epinephrine—Dizziness—Docetaxel—breast cancer	4.45e-05	0.000333	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—breast cancer	4.45e-05	0.000333	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—breast cancer	4.43e-05	0.000332	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—breast cancer	4.41e-05	0.00033	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—breast cancer	4.39e-05	0.000329	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—breast cancer	4.39e-05	0.000328	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—breast cancer	4.39e-05	0.000328	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—breast cancer	4.36e-05	0.000326	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.36e-05	0.000326	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—breast cancer	4.32e-05	0.000323	CcSEcCtD
Epinephrine—Dizziness—Capecitabine—breast cancer	4.31e-05	0.000323	CcSEcCtD
Epinephrine—Vomiting—Docetaxel—breast cancer	4.28e-05	0.00032	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—breast cancer	4.19e-05	0.000314	CcSEcCtD
Epinephrine—Vomiting—Capecitabine—breast cancer	4.15e-05	0.00031	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—breast cancer	4.12e-05	0.000308	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—breast cancer	4.11e-05	0.000307	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—breast cancer	4.1e-05	0.000307	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—breast cancer	4.08e-05	0.000305	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—breast cancer	4.08e-05	0.000305	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—breast cancer	4.06e-05	0.000304	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—breast cancer	4.04e-05	0.000302	CcSEcCtD
Epinephrine—Nausea—Docetaxel—breast cancer	4e-05	0.000299	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Epirubicin—breast cancer	3.92e-05	0.000293	CcSEcCtD
Epinephrine—Nausea—Capecitabine—breast cancer	3.87e-05	0.00029	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—breast cancer	3.8e-05	0.000284	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—breast cancer	3.77e-05	0.000282	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—breast cancer	3.74e-05	0.00028	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.63e-05	0.000271	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—breast cancer	3.21e-05	0.00024	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—breast cancer	3.09e-05	0.000231	CcSEcCtD
Epinephrine—Dizziness—Epirubicin—breast cancer	3e-05	0.000225	CcSEcCtD
Epinephrine—Vomiting—Epirubicin—breast cancer	2.89e-05	0.000216	CcSEcCtD
Epinephrine—Nausea—Methotrexate—breast cancer	2.88e-05	0.000216	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—breast cancer	2.78e-05	0.000208	CcSEcCtD
Epinephrine—Nausea—Epirubicin—breast cancer	2.7e-05	0.000202	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—breast cancer	2.67e-05	0.0002	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—breast cancer	2.5e-05	0.000187	CcSEcCtD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	1.3e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTEN—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—breast cancer	1.29e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTEN—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.27e-06	9.99e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK8—breast cancer	1.27e-06	9.98e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—breast cancer	1.26e-06	9.97e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—breast cancer	1.26e-06	9.96e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—breast cancer	1.26e-06	9.96e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.26e-06	9.95e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.26e-06	9.92e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAV1—breast cancer	1.26e-06	9.92e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.26e-06	9.91e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.25e-06	9.88e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—breast cancer	1.25e-06	9.88e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.25e-06	9.86e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.25e-06	9.86e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—JUN—breast cancer	1.25e-06	9.86e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.25e-06	9.84e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RELA—breast cancer	1.25e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.25e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	1.24e-06	9.78e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ERCC2—breast cancer	1.24e-06	9.78e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.24e-06	9.77e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.23e-06	9.72e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.23e-06	9.71e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—JUN—breast cancer	1.23e-06	9.7e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.22e-06	9.66e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.22e-06	9.64e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.22e-06	9.64e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	9.63e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.22e-06	9.59e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NCOA1—breast cancer	1.21e-06	9.58e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.21e-06	9.55e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SRC—breast cancer	1.21e-06	9.55e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.21e-06	9.53e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.2e-06	9.48e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SRC—breast cancer	1.2e-06	9.46e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.2e-06	9.44e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.2e-06	9.44e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—STK11—breast cancer	1.2e-06	9.44e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.19e-06	9.4e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—breast cancer	1.19e-06	9.39e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.19e-06	9.38e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.19e-06	9.37e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SRC—breast cancer	1.18e-06	9.34e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.18e-06	9.33e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.18e-06	9.3e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.18e-06	9.3e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.17e-06	9.27e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTEN—breast cancer	1.17e-06	9.26e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.17e-06	9.25e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.17e-06	9.22e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—breast cancer	1.17e-06	9.21e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.17e-06	9.21e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.17e-06	9.21e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—breast cancer	1.16e-06	9.19e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.16e-06	9.19e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.16e-06	9.18e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.16e-06	9.18e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.16e-06	9.15e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.16e-06	9.14e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.16e-06	9.13e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.15e-06	9.1e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.15e-06	9.08e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.15e-06	9.05e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.14e-06	9.03e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—breast cancer	1.14e-06	9.01e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.14e-06	8.96e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.14e-06	8.96e-06	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.13e-06	8.95e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.12e-06	8.87e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.12e-06	8.86e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SRC—breast cancer	1.12e-06	8.84e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.12e-06	8.81e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.12e-06	8.8e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—COMT—breast cancer	1.11e-06	8.77e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTP1—breast cancer	1.11e-06	8.73e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.1e-06	8.72e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.1e-06	8.7e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.1e-06	8.68e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.09e-06	8.63e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.09e-06	8.62e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMOX1—breast cancer	1.09e-06	8.61e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.09e-06	8.61e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.09e-06	8.61e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.09e-06	8.61e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ITPR1—breast cancer	1.09e-06	8.59e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—breast cancer	1.08e-06	8.56e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.08e-06	8.56e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.08e-06	8.55e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.08e-06	8.54e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.08e-06	8.53e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—breast cancer	1.07e-06	8.48e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAV1—breast cancer	1.07e-06	8.48e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.07e-06	8.47e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.07e-06	8.46e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.07e-06	8.41e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.06e-06	8.39e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.06e-06	8.38e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—breast cancer	1.06e-06	8.37e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—breast cancer	1.06e-06	8.37e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.06e-06	8.35e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.06e-06	8.35e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.06e-06	8.33e-06	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.05e-06	8.32e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.05e-06	8.3e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—breast cancer	1.05e-06	8.27e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCB1—breast cancer	1.05e-06	8.27e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.04e-06	8.24e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.04e-06	8.23e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—breast cancer	1.04e-06	8.19e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.04e-06	8.19e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.03e-06	8.15e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.03e-06	8.15e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.03e-06	8.13e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TYMS—breast cancer	1.03e-06	8.12e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.03e-06	8.1e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.02e-06	8.04e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.02e-06	8.02e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NCOR1—breast cancer	1.02e-06	8.02e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTM1—breast cancer	1.02e-06	8.02e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.02e-06	8.02e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.02e-06	8.02e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.01e-06	8.01e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.01e-06	7.97e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.01e-06	7.94e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.01e-06	7.94e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—breast cancer	1e-06	7.92e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—breast cancer	1e-06	7.91e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1e-06	7.9e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—breast cancer	9.94e-07	7.84e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—breast cancer	9.93e-07	7.84e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—breast cancer	9.88e-07	7.8e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—breast cancer	9.87e-07	7.79e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	9.86e-07	7.78e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	9.83e-07	7.76e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—breast cancer	9.82e-07	7.75e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTEN—breast cancer	9.81e-07	7.74e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—breast cancer	9.8e-07	7.74e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SRC—breast cancer	9.79e-07	7.73e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CG—breast cancer	9.78e-07	7.72e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—breast cancer	9.78e-07	7.71e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—breast cancer	9.77e-07	7.71e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—breast cancer	9.74e-07	7.68e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—breast cancer	9.66e-07	7.63e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.64e-07	7.61e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	9.6e-07	7.57e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	9.57e-07	7.55e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ERCC2—breast cancer	9.56e-07	7.54e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	9.54e-07	7.53e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—breast cancer	9.5e-07	7.5e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.44e-07	7.45e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—breast cancer	9.35e-07	7.38e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—breast cancer	9.28e-07	7.32e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	9.21e-07	7.27e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—breast cancer	9.13e-07	7.2e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	9.12e-07	7.2e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SRC—breast cancer	9.1e-07	7.18e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	9.02e-07	7.12e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	9.01e-07	7.11e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—breast cancer	8.99e-07	7.09e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—breast cancer	8.95e-07	7.06e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—breast cancer	8.91e-07	7.03e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	8.86e-07	6.99e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—breast cancer	8.83e-07	6.97e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—breast cancer	8.78e-07	6.93e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—breast cancer	8.78e-07	6.92e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.77e-07	6.92e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	8.75e-07	6.91e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—breast cancer	8.71e-07	6.88e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—breast cancer	8.69e-07	6.86e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CD—breast cancer	8.6e-07	6.79e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—breast cancer	8.58e-07	6.77e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—breast cancer	8.56e-07	6.76e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	8.52e-07	6.73e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—breast cancer	8.52e-07	6.72e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—breast cancer	8.49e-07	6.7e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—breast cancer	8.44e-07	6.66e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.39e-07	6.62e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.38e-07	6.62e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—breast cancer	8.33e-07	6.58e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—breast cancer	8.33e-07	6.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAV1—breast cancer	8.29e-07	6.54e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—breast cancer	8.28e-07	6.53e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—breast cancer	8.26e-07	6.51e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—breast cancer	8.24e-07	6.51e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—breast cancer	8.15e-07	6.43e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—breast cancer	8.15e-07	6.43e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	8.13e-07	6.42e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—breast cancer	8.12e-07	6.41e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—breast cancer	8.11e-07	6.4e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—breast cancer	8.11e-07	6.4e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—breast cancer	8.08e-07	6.38e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—breast cancer	7.98e-07	6.3e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—breast cancer	7.98e-07	6.29e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—breast cancer	7.98e-07	6.29e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—breast cancer	7.88e-07	6.22e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—breast cancer	7.76e-07	6.12e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTEN—breast cancer	7.58e-07	5.98e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.55e-07	5.96e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—breast cancer	7.55e-07	5.96e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.53e-07	5.95e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—breast cancer	7.52e-07	5.94e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CB—breast cancer	7.5e-07	5.92e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—breast cancer	7.45e-07	5.88e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.45e-07	5.88e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—breast cancer	7.43e-07	5.86e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—breast cancer	7.43e-07	5.86e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—breast cancer	7.36e-07	5.81e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—breast cancer	7.21e-07	5.69e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—breast cancer	6.96e-07	5.49e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	6.92e-07	5.46e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—breast cancer	6.89e-07	5.44e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—breast cancer	6.85e-07	5.41e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—breast cancer	6.76e-07	5.34e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—breast cancer	6.7e-07	5.28e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.64e-07	5.24e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—breast cancer	6.6e-07	5.21e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—breast cancer	6.55e-07	5.17e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTEN—breast cancer	6.48e-07	5.11e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.4e-07	5.05e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—breast cancer	6.27e-07	4.95e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—breast cancer	6.13e-07	4.84e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—breast cancer	6.09e-07	4.8e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.79e-07	4.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—breast cancer	5.73e-07	4.52e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.65e-07	4.46e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.35e-07	4.22e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTEN—breast cancer	5e-07	3.95e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.57e-07	3.61e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—breast cancer	4.37e-07	3.45e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—breast cancer	3.73e-07	2.95e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.53e-07	2.78e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—breast cancer	2.88e-07	2.27e-06	CbGpPWpGaD
